Serbia Advances EU Regulatory Alignment Through Tax, Health and Environmental Reforms

Serbia’s government has approved a broad package of legislative measures aimed at bringing key parts of the country’s regulatory system closer to the European Union framework, covering corporate taxation, employment incentives, social-security contributions, pharmaceuticals, tobacco regulation, higher education and environmental policy.

The measures represent a further step in implementing Serbia’s 2024–2027 Reform Agenda and are linked to the country’s access to approximately €1.58 billion allocated through the European Union’s Reform and Growth Facility for the Western Balkans. The package still requires legislative approval, with tax and employment-related amendments expected to proceed through the National Assembly. Their practical impact will depend on implementing regulations, administrative procedures and the ability of relevant institutions, including tax authorities, state-aid bodies, inspectors and health agencies, to apply the rules consistently.

For businesses operating in Serbia, the measures indicate that EU alignment is moving from strategic commitments into specific regulations affecting investment incentives, labour costs, product compliance and market access.

Employment Incentives Face EU State-Aid Alignment Rules

Amendments to the Law on Contributions for Compulsory Social Insurance would align employment incentives with EU principles governing state aid. Related changes to the Personal Income Tax Law would modify tax relief available for companies hiring new employees under the same approach.

Serbia has traditionally used payroll tax reductions and social contribution incentives to encourage formal employment, attract investment and reduce workforce expansion costs. Such measures have been particularly relevant for labour-intensive manufacturing, technology companies, shared-service centres, logistics operators, engineering firms and business-process outsourcing providers. Under EU state-aid principles, employment support remains possible but must meet requirements related to transparency, proportionality and competition. Incentives generally need a defined policy purpose and must avoid creating disproportionate advantages for individual companies.

Companies operating under existing support schemes will need to assess issues such as eligibility periods, aid intensity limits and the interaction between employment incentives and other public assistance. Businesses receiving investment subsidies, payroll support or infrastructure assistance may increasingly need to evaluate these measures as part of a combined state-aid framework.

Foreign manufacturers that entered Serbia through investment agreements involving direct job subsidies, land support, infrastructure assistance or tax benefits may face greater documentation requirements. Corporate groups are expected to maintain records showing the legal basis, value, duration and purpose of all public support received. Such documentation may become important during acquisitions, refinancing processes, transfer-pricing reviews and international lender due diligence, particularly where potential liabilities could arise from incorrectly combined or insufficiently documented state support.

Corporate Tax Rules Move Toward EU-Compatible Framework

The government has also approved amendments to Serbia’s Corporate Income Tax Law, continuing efforts to align domestic taxation with EU standards. Serbia’s corporate income tax rate of 15% remains unchanged and continues to represent one of the country’s investment advantages. However, international companies increasingly assess tax competitiveness through broader criteria, including related-party transactions, beneficial ownership rules, interest deductions, cross-border payments, economic substance requirements and global minimum taxation obligations.

Closer alignment with EU tax concepts could reduce compliance differences between Serbian subsidiaries and European parent companies, potentially simplifying reporting procedures and lowering administrative costs. The shift also reduces reliance on selective tax advantages as a tool for attracting investment. Future competitiveness is expected to depend more heavily on infrastructure quality, workforce availability, energy supply, administrative efficiency and integration into European supply chains.

For long-term industrial investors, including manufacturers, processing companies and logistics operators, predictable tax administration can become more important than temporary incentives that may require later regulatory reassessment.

Tobacco Rules Introduce New Compliance Requirements

The reform package includes amendments to the Tobacco Law, which would clarify inspection authorities’ powers, delay certain deadlines related to product marking obligations and establish new rules for recording and placing existing inventories on the market. The changes address compliance risks for products manufactured, imported or stored before new marking and traceability requirements enter into force.

For tobacco producers, importers, wholesalers and retailers, transitional provisions will determine whether existing stocks can continue to be sold, require relabelling or must be removed from circulation. The revised framework moves the sector toward stronger product traceability, stricter excise control and improved monitoring of supply-chain movements. Companies will need reliable records linking production batches, tax markings, invoices, warehouse transfers and retail distribution.

Pharmaceutical Market Expands With New Reimbursement Measures

The government approved changes to Serbia’s pharmaceutical reimbursement system through a revised list of medicines financed by compulsory health insurance and amendments regulating maximum medicine prices. The updated reimbursement list will reduce patient co-payments for 769 medicines included in the A1 reimbursement category. It will also introduce 145 additional prescription medicines to the market, including innovative treatments for rare diseases, cancer, cardiovascular conditions and other serious illnesses, alongside additional generic medicines.

The changes are expected to improve patient access while creating new market opportunities for pharmaceutical manufacturers, distributors, pharmacies and specialised logistics companies. For pharmaceutical companies, reimbursement status is a key commercial factor because products covered by the national health-insurance system gain access to a significantly larger patient base. However, reimbursement expansion is accompanied by regulated prices, reimbursement conditions and potential pressure on profit margins.

The financial impact will depend on the balance between increased medicine availability, regulated prices and greater use of generic alternatives. Expanded access could initially increase public healthcare spending, while price controls and improved treatment management could reduce costs over time. Serbia’s pharmaceutical market remains relevant for international companies due to its population size, centralised reimbursement system and position as a distribution hub for the Western Balkans.

Universities Restore Previous Academic Workload Structure

The government has also approved the return to previous rules governing academic staff working hours. At universities and faculties, the standard allocation will again be 20 hours per week for scientific research or artistic work and 20 hours for teaching. At academies and colleges of applied studies, staff will return to 10 hours for professional or artistic work and 30 hours for teaching.

Temporary arrangements introduced in 2025 increased teaching obligations to help universities recover classes disrupted during the 2024/2025 and 2025/2026 academic years. The government stated that the circumstances requiring those measures had ended. The restoration of research time could support cooperation between universities and industry, participation in international projects and development of technical skills needed in advanced manufacturing, digital services, energy engineering, environmental management and pharmaceutical research.

Green Agenda Strategy Sets Direction for Future Investment Rules

The government adopted Serbia’s Environmental Protection Strategy – Green Agenda through 2033, establishing a framework for environmental improvement, sustainable development and quality-of-life objectives. The strategy has direct relevance for investment sectors including energy, mining, heavy industry, construction, waste management, water treatment, agriculture and transport.

Serbia faces significant investment needs to align with EU environmental requirements, particularly in industrial emissions control, wastewater treatment, air-quality management, waste infrastructure, nature protection and climate monitoring. The strategy does not directly finance projects but establishes future priorities for legislation, permitting procedures, public investment programmes and enforcement.

Companies planning long-term assets in Serbia will increasingly need to consider environmental standards expected under future EU alignment rather than only current domestic requirements. For industrial facilities, future capital requirements may include emissions-control equipment, wastewater treatment systems, continuous monitoring technology, energy-efficiency upgrades, waste-management infrastructure and remediation measures. International lenders and financial institutions, including the European Bank for Reconstruction and Development and the European Investment Bank, increasingly require projects to demonstrate compliance with environmental and social standards that often exceed existing national requirements.

EU Reform Funding Linked to Legislative Progress

Serbia’s reform measures are connected to financial support available under the EU Growth Plan for the Western Balkans for 2024–2027, which provides approximately €1.58 billion through grants and concessional loans. The country has already received around €111 million in pre-financing, while a further €56.5 million first tranche was approved after the European Commission confirmed completion of three agreed reform steps. Serbia submitted an additional payment request worth approximately €95 million in January 2026.

EU funding under the mechanism depends on verified completion of reform milestones covering the business environment, digital and green transition, human capital development and institutional reforms. The financing provides Serbia with access to lower-cost funding and can support public investment capacity, while consistent reform implementation may influence investor confidence and financing conditions. The effectiveness of the latest legislative package will ultimately depend on implementation. Businesses require predictable enforcement, transparent secondary regulations and consistent interpretation across institutions to translate formal EU alignment into practical regulatory certainty.